Daily spirometry in an acute exacerbation of adult cystic fibrosis patients

被引：3

作者：

Stephen, Michael J. ^{[1
]}

Long, Alex ^{[2
]}

Bonsall, Chad ^{[3
]}

Hoag, Jeffrey B. ^{[1
]}

Shah, Smita ^{[4
]}

Bisberg, Dorothy ^{[4
]}

Holsclaw, Douglas ^{[3
]}

Varlotta, Laurie ^{[5
]}

Fiel, Stan ^{[6
]}

Du, Doantrang ^{[7
]}

Zanni, Robert ^{[7
]}

Hadjiliadis, Denis ^{[3
]}

机构：

[1] Drexel Univ, Sch Med, Div Pulm & Crit Care, Philadelphia, PA USA

[2] Drexel Univ, Sch Publ Hlth, Philadelphia, PA USA

[3] Univ Penn, Div Pulm & Crit Care, Philadelphia, PA USA

[4] Pediat Specialty Ctr, St Barnabas Med Ctr, Barnabas Hlth Med Grp, W Orange, NJ USA

[5] St Christophers Hosp Children, Philadelphia, PA USA

[6] Atlantic Hlth Syst, Morristown, NJ USA

[7] Monmouth Med Ctr, Long Branch, NJ USA

来源：

CHRONIC RESPIRATORY DISEASE | 2018年 / 15卷 / 03期

关键词：

Cystic fibrosis; acute exacerbation; home spirometry; CFQ-R; intravenous antibiotics; QUALITY-OF-LIFE; PULMONARY EXACERBATIONS; RESPIRATORY EXACERBATIONS; ANTIBIOTIC-TREATMENT; MORTALITY; OUTCOMES;

D O I：

10.1177/1479972317743756

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

To help answer the question of length of intravenous antibiotics during an acute exacerbation of cystic fibrosis (CF), we had subjects to follow daily home spirometry while on intravenous antibiotics. CF patients, 18 and older, with an acute exacerbation requiring intravenous antibiotics had a daily FEV1. The average time to a 10% increase over their initial sick FEV1 was calculated, as well as the time to a new baseline. A total of 25 subjects completed the study. Ten of the 25 subjects did not have a sustainable 10% increase in FEV1. Of the 15 subjects with a sustainable 10% increase in FEV1, it took 5.2 days (+/- 4.5) after day 1, while a new baseline was achieved on average at 6.6 days (+/- 4.8) after day 1. Given the wide range of time to a 10% improvement and new baseline, it is recommended there should be flexibility in length of intravenous antibiotics in CF, not by a preset number.

引用

页码：258 / 264

页数：7

共 50 条

[41] USE OF CHECKLISTS TO ASSIST PATIENTS WITH EARLY RECOGNITION OF ACUTE PULMONARY EXACERBATION IN CYSTIC FIBROSIS
Gutierrez, H.
Self, S.
Mims, C.
PEDIATRIC PULMONOLOGY, 2011, : 384 - 384
[42] High-flow oxygen therapy for the management of patients with acute exacerbation of cystic fibrosis
Thille, Arnaud W.
Joly, Florent
Marjanovic, Nicolas
Frat, Jean-Pierre
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
[43] ACUTE CORONARY SYNDROME PRESENTING AS A CYSTIC FIBROSIS PULMONARY EXACERBATION
Olivero, Anthony
CRITICAL CARE MEDICINE, 2012, 40 (12) : U331 - U331
[44] Breath isoprene during acute respiratory exacerbation in cystic fibrosis
McGrath, LT
Patrick, R
Mallon, P
Dowey, L
Silke, B
Norwood, W
Elborn, S
EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (06) : 1065 - 1069
[45] The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation
Etherington, C.
Naseer, R.
Conway, S. P.
Whitaker, P.
Denton, M.
Peckham, D. G.
JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (01) : 49 - 55
[46] Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis
Sequeiros, Iara Maria
Jarad, Nabil
CHRONIC RESPIRATORY DISEASE, 2012, 9 (01) : 9 - 16
[47] Feasibility of telehealth spirometry for patients with cystic fibrosis in a regional setting
Hatziagorou, E.
Sopiadou, A.
Kogias, C.
Gioulvanidou, M.
Chrysochoou, E.
Kalaitzopoulou, I.
Peftoulidou, P.
Tsanakas, J.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[48] Acute effect of exercise on ventilation inhomogeneity in adult cystic fibrosis patients
Kaltsakas, Georgios
Anastasopoulos, Nikolaos
Chynkiamis, Nikolaos
Kotsifas, Konstantinos
Iglezos, Ilias
Vogiatzis, Ioarmis
Koulouris, Nickolaos G.
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[49] Assessing the quality of home spirometry at a single centre adult cystic fibrosis service
Smith, Iain
Wood, Michelle
McMahon, Tracy
Lacey, Andrea
Smith, Daniel
RESPIROLOGY, 2024, 29 : 8 - 9
[50] The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
Carmody, Lisa A.
Zhao, Jiangchao
Kalikin, Linda M.
LeBar, William
Simon, Richard H.
Venkataraman, Arvind
Schmidt, Thomas M.
Abdo, Zaid
Schloss, Patrick D.
LiPuma, John J.
MICROBIOME, 2015, 3

← 1 2 3 4 5 →